Similar articles

• Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997-2009.

  Snowden JA, Pearce RM, Lee J, Kirkland K, Gilleece M, Veys P, Clark RE, Kazmi M, Abinun M, Jackson GH, Mackinnon S, Russell NH, Cook G; BSBMT Clinical Trials Committee. Snowden JA, et al. Br J Haematol. 2012 Jun;157(6):742-6. doi: 10.1111/j.1365-2141.2012.09122.x. Epub 2012 Apr 26. Br J Haematol. 2012. PMID: 22533715 Clinical Trial.
• Management of autoimmune diseases after haematopoietic stem cell transplantation.

  Holbro A, Abinun M, Daikeler T. Holbro A, et al. Br J Haematol. 2012 May;157(3):281-90. doi: 10.1111/j.1365-2141.2012.09070.x. Epub 2012 Feb 24. Br J Haematol. 2012. PMID: 22360687 Review.
• Allogeneic haematopoietic stem cell transplantation for severe autoimmune diseases: great expectations but controversial evidence.

  Marmont AM. Marmont AM. Bone Marrow Transplant. 2006 Jul;38(1):1-4. doi: 10.1038/sj.bmt.1705394. Bone Marrow Transplant. 2006. PMID: 16788682 No abstract available.
• Autologous stem cell transplantation for treatment of autoimmune diseases.

  van Bekkum DW. van Bekkum DW. Stem Cells. 1999;17(3):172-8. doi: 10.1002/stem.170172. Stem Cells. 1999. PMID: 10342560 Review. No abstract available.
• Experimental basis for the treatment of autoimmune diseases with autologous hematopoietic stem cell transplantation.

  Van Bekkum DW. Van Bekkum DW. Bone Marrow Transplant. 2003 Aug;32 Suppl 1:S37-9. doi: 10.1038/sj.bmt.1703941. Bone Marrow Transplant. 2003. PMID: 12931239 Review.